Amplatzer封堵器用于先心病动脉导管未闭及Ⅱ孔型房间隔缺损介入治疗的经验总结  

The experiences of Amplatzer occluder usefulness in the treatments for patent ductus arteriosus and secundum atrial septal defect and the prevention of the complications

作　　者：金泽宁[1] 张金荣[1] 刘文娴[1] 陈欣[1] 

机构地区：[1]北京心肺血管疾病研究所,首都医科大学附属北京安贞医院心内科,100029

出　　处：《介入放射学杂志》2003年第S1期58-59,共2页Journal of Interventional Radiology

摘　　要：目的　对 12 3例患者使用AmplatzerPDA及Ⅱ孔型ASD封堵器的经验教训作一总结。 方法　对象取自 1993～ 2 0 0 2年间于首都医科大学附属北京安贞医院心内科接受Amplatzer介入治疗的PDA患者 32例 ,Ⅱ孔型ASD患者 91例共 12 3例。结果　PDA封堵伞置入成功率为 96 .8% ,合并症发生率为 6 .2 5 % ;Ⅱ孔型ASD封堵伞置入成功率为 97.8% ,合并症发生率为 2 .2 %。结论　对于先心病PDA和ASD的介入治疗而言 ,Amplatzer是较为安全和可控性强的装置 ,可安全地应用于临床适应证患者。Objective Amplatzer occulders for Patent Ductus Arteriosus(PDA) and Secundum Atrial Septal Defect (ASD) were approved by the FDA for the clinical use in 1997 and it gained popularity for its safety, effectiveness and easy retrievable. This was a single center trial for the summary of the experiences of Amplatzer occluder usefulness in the treatments for Secundum ASD and PDA and the prevention of complications. Methods This was a descriptive study. We chose the 123 patients receiving the Amplatzer Occlud...

关 键 词：动脉导管未闭 房间隔缺损 AMPLATZER封堵伞 

分 类 号：R541.1[医药卫生—心血管疾病]